Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice

類似資料

• Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice.
  著者:: Ji Eun Park, 等
  出版事項: (2017-01-01)
• Polymer Micelle Formulations of Proteasome Inhibitor Carfilzomib for Improved Metabolic Stability and Anticancer Efficacy in Human Multiple Myeloma and Lung Cancer Cell Lines
  著者:: Ao, Lin, 等
  出版事項: (2015)
• H727 cells are inherently resistant to the proteasome inhibitor carfilzomib, yet require proteasome activity for cell survival and growth
  著者:: Lee, Min Jae, 等
  出版事項: (2019)
• Expanding Therapeutic Utility of Carfilzomib for Breast Cancer Therapy by Novel Albumin-coated Nanocrystal Formulation
  著者:: Park, Ji Eun, 等
  出版事項: (2019)
• Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib
  著者:: Lee, Min Jae, 等
  出版事項: (2019)